Tag Archives: OCX

Top 10 Blue Chip Stocks To Invest In Right Now

The tax bill passed by the House and Senate still hasn’t been signed by President Trump. But one blue chip company, FedEx, is already touting the potential for a nearly $1.5 billion increase in annual profits due to lower corporate taxes.

FedEx reported its latest quarterly results after the closing bell Tuesday, before the Senate voted to approve the bill.

But the shipping giant told investors in its earnings release that its annual profits for fiscal 2018 could increase by $4.40 to $5.50 a share, mainly due to a change in how it values deferred tax liabilities as well as the cut in the corporate tax rate to 21%.

The lower tax rate on its own will lead earnings to be as much as $1 share higher, FedEx said.

FedEx has about 268.2 million total shares outstanding. So a possible $5.50 per share boost from lower taxes would translate to a $1.48 billion bump in annual earnings. Shares of FedEx (FDX) rose more than 3% on the news, hitting an all-time high.

Top 10 Blue Chip Stocks To Invest In Right Now: Internet Gold Golden Lines Ltd.(IGLD)

Advisors’ Opinion:

  • [By Max Byerly]

    Media stories about Internet Gold Golden Lines (NASDAQ:IGLD) have trended somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Internet Gold Golden Lines earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 47.7616640405736 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top 10 Blue Chip Stocks To Invest In Right Now: Archrock, Inc.(AROC)

Advisors’ Opinion:

  • [By ]

    As it happens, I am familiar with about half of these stocks. Archrock (Nasdaq: AROC), Qualcomm (Nasdaq: QCOM), Schlumberger (NYSE: SLB, and Trinity Industries (NYSE: TRN) are all interesting names that I’ve either owned in the past or have written about recently over at High-Yield Investing.

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Bailard Inc. Has $381,000 Holdings in Archrock Inc (AROC)” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another domain, it was stolen and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/4150167/bailard-inc-has-381000-holdings-in-archrock-inc-aroc.html.

  • [By Ethan Ryder]

    Archrock (NYSE:AROC) posted its quarterly earnings data on Tuesday. The energy company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02, Briefing.com reports. The firm had revenue of $233.20 million during the quarter, compared to analysts’ expectations of $232.15 million. Archrock had a net margin of 6.32% and a return on equity of 2.49%. The business’s revenue was up 11.6% compared to the same quarter last year.

  • [By Ethan Ryder]

    News stories about Archrock (NYSE:AROC) have trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Archrock earned a coverage optimism score of 0.12 on Accern’s scale. Accern also gave headlines about the energy company an impact score of 47.3449329112104 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Top 10 Blue Chip Stocks To Invest In Right Now: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    OncoCyte Corp. (NYSE: OCX) was started as Overweight with a $6 price target (versus a $3.84 close) at Piper Jaffray. It has a 52-week range of $1.10 to $6.92 and a market cap of only $191 million.

  • [By Money Morning News Team]

    You only have to review the one-week gains of some of the top penny stocks to see how much investors can benefit. The top performer recently, OncoCyte Corp. (NYSE: OCX), skyrocketed almost 160% on the week. Yet it can still be purchased at only $4.98 per share.

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Blue Chip Stocks To Invest In Right Now: Israel Chemicals Shs(ICL)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Israel Chemicals (NYSE:ICL) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

    Kingstone Companies (NASDAQ:KINS) was upgraded by analysts at ValuEngine from a hold rating to a buy rating.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Israel Chemicals (ICL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Schroder Investment Management Group boosted its position in shares of Israel Chemicals Ltd (NYSE:ICL) by 43.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 655,043 shares of the basic materials company’s stock after acquiring an additional 199,511 shares during the period. Schroder Investment Management Group owned approximately 0.05% of Israel Chemicals worth $10,939,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Itasca Capital Ltd (CVE:ICL) Director Richard Michael Powell bought 25,000 shares of the company’s stock in a transaction on Monday, August 13th. The shares were bought at an average cost of C$0.57 per share, for a total transaction of C$14,250.00.

Top 10 Blue Chip Stocks To Invest In Right Now: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cott (COT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Cott Corp (NYSE:COT) (TSE:BCB) Director Steven P. Stanbrook purchased 13,500 shares of the company’s stock in a transaction dated Tuesday, February 26th. The stock was purchased at an average price of $14.77 per share, with a total value of $199,395.00. Following the transaction, the director now owns 13,500 shares of the company’s stock, valued at $199,395. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website.

  • [By Logan Wallace]

    GSA Capital Partners LLP grew its holdings in Cott Corp (NYSE:COT) (TSE:BCB) by 185.1% during the 2nd quarter, Holdings Channel reports. The firm owned 152,168 shares of the company’s stock after purchasing an additional 98,796 shares during the quarter. GSA Capital Partners LLP’s holdings in Cott were worth $2,518,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Cott (NYSE:COT) (TSE:BCB) was upgraded by analysts at Jefferies Group from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, MarketBeat reports. The firm currently has a $17.00 price objective on the stock. Jefferies Group’s price target indicates a potential upside of 6.25% from the stock’s previous close. Jefferies Group also issued estimates for Cott’s Q2 2018 earnings at $0.06 EPS, Q3 2018 earnings at $0.14 EPS, Q4 2018 earnings at $0.01 EPS and FY2020 earnings at $0.38 EPS.

  • [By Stephan Byrd]

    Cott (NYSE:COT) (TSE:BCB) last announced its quarterly earnings results on Thursday, May 3rd. The company reported ($0.02) earnings per share for the quarter, meeting the Zacks’ consensus estimate of ($0.02). Cott had a net margin of 14.54% and a return on equity of 1.79%. The firm had revenue of $560.80 million for the quarter, compared to analyst estimates of $563.81 million. During the same quarter in the previous year, the firm posted ($0.07) earnings per share. The business’s revenue was up 4.5% on a year-over-year basis. sell-side analysts anticipate that Cott will post 0.21 earnings per share for the current fiscal year.

Top 10 Blue Chip Stocks To Invest In Right Now: Cross Country Healthcare, Inc.(CCRN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) – Research analysts at SunTrust Banks dropped their Q1 2019 earnings estimates for Cross Country Healthcare in a report issued on Tuesday, February 19th. SunTrust Banks analyst T. Sommer now expects that the business services provider will post earnings per share of ($0.01) for the quarter, down from their prior forecast of $0.01. SunTrust Banks has a “Hold” rating on the stock. SunTrust Banks also issued estimates for Cross Country Healthcare’s Q2 2019 earnings at $0.01 EPS, Q1 2020 earnings at ($0.01) EPS and Q2 2020 earnings at $0.04 EPS.

  • [By ]

    Activist investor Glenn Welling of Engaged Capital LLC, the insurgent investor agitating for changes at TiVo, Rent-a-Center, on Tuesday, May 15, revealed new positions in Aratana Therapeutics Inc. (PETX) , Cross Country Healthcare Inc. (CCRN)  and Finisar Corp. (FNSR)

  • [By Joseph Griffin]

    Cross Country Healthcare, Inc. (NASDAQ:CCRN) has received an average recommendation of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $14.00.

  • [By Ethan Ryder]

    Cross Country Healthcare (NASDAQ:CCRN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Cross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. “

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Blue Chip Stocks To Invest In Right Now: AmerisourceBergen Corporation (Holding Co)(ABC)

Advisors’ Opinion:

  • [By Motley Fool Transcribing]

    AmerisourceBergen (NYSE:ABC) Q1 2019 Earnings Conference CallJan. 31, 2019 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    COPYRIGHT VIOLATION NOTICE: “Sivik Global Healthcare LLC Has $744,000 Holdings in AmerisourceBergen Corp. (ABC)” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4194514/sivik-global-healthcare-llc-has-744000-holdings-in-amerisourcebergen-corp-abc.html.

  • [By Stephan Byrd]

    Golub Group LLC increased its holdings in shares of AmerisourceBergen Corp. (NYSE:ABC) by 11.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,519 shares of the company’s stock after purchasing an additional 1,691 shares during the quarter. Golub Group LLC’s holdings in AmerisourceBergen were worth $1,229,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Peel Hunt restated their buy rating on shares of Abcam (LON:ABC) in a report issued on Monday morning.

    A number of other equities research analysts have also commented on ABC. Numis Securities upgraded Abcam to an add rating and set a GBX 1,340 ($17.51) target price on the stock in a research report on Tuesday, January 8th. JPMorgan Chase & Co. reiterated a neutral rating on shares of Abcam in a research report on Thursday, January 10th. Finally, Berenberg Bank reiterated a buy rating and issued a GBX 1,640 ($21.43) target price on shares of Abcam in a research report on Tuesday, January 8th.

  • [By Ethan Ryder]

    Alphabit (CURRENCY:ABC) traded down 14.2% against the US dollar during the 24-hour period ending at 19:00 PM Eastern on April 11th. Alphabit has a market cap of $0.00 and approximately $999.00 worth of Alphabit was traded on exchanges in the last 24 hours. One Alphabit token can now be purchased for about $33.91 or 0.00489408 BTC on cryptocurrency exchanges including C-CEX and Cryptopia. In the last week, Alphabit has traded up 2.4% against the US dollar.

  • [By Logan Wallace]

    AmerisourceBergen (NYSE: ABC) and Trxade Group (OTCMKTS:TRXD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, dividends, earnings, institutional ownership and profitability.

Top 10 Blue Chip Stocks To Invest In Right Now: Monsanto Company(MON)

Advisors’ Opinion:

  • [By Logan Wallace]

    Global X Management Co. LLC trimmed its stake in shares of Monsanto (NYSE:MON) by 6.8% during the first quarter, HoldingsChannel.com reports. The fund owned 11,141 shares of the basic materials company’s stock after selling 818 shares during the period. Global X Management Co. LLC’s holdings in Monsanto were worth $1,300,000 as of its most recent SEC filing.

  • [By Matthew Frankel]

    Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B), the conglomerate led by billionaire investor Warren Buffett, is officially receiving a nice windfall of cash. The acquisition of agricultural giant Monsanto (NYSE:MON) by Germany’s Bayer (NASDAQOTH:BAYRY) in an all-cash deal is putting more than $2.4 billion back into Berkshire’s coffers.

  • [By ]

    What Buffett Is Buying Now…
    And speaking of the Oracle of Omaha, recent reports on insider activity included news that Buffett recently increased his stake in high-tech farming giant, Monsanto (NYSE: MON).

  • [By ]

    In addition, Corvex Management’s Keith Meister reported owning new significant stakes in Intercontinental Exchange Inc. ( (ICE) ), Microsoft Corp.  (MSFT) , Monsanto Co. (MON) , Qualcomm Inc. (QCOM) , Salesforce.com Inc. (CRM) and Servicenow Inc. (NOW)

Top 10 Blue Chip Stocks To Invest In Right Now: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Sawtooth Solutions LLC bought a new position in Principal Financial Group Inc (NYSE:PFG) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 17,428 shares of the financial services provider’s stock, valued at approximately $922,000.

  • [By Logan Wallace]

    ING Groep NV boosted its stake in Principal Financial Group Inc (NYSE:PFG) by 7.8% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 27,524 shares of the financial services provider’s stock after purchasing an additional 1,991 shares during the period. ING Groep NV’s holdings in Principal Financial Group were worth $1,676,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Max Byerly]

    Shore Capital reissued their hold rating on shares of Provident Financial (LON:PFG) in a report issued on Thursday.

    PFG has been the subject of several other reports. Liberum Capital reissued a sell rating and set a GBX 483 ($6.48) price objective on shares of Provident Financial in a research note on Monday, February 26th. Peel Hunt reissued a hold rating and set a GBX 870 ($11.67) price objective on shares of Provident Financial in a research note on Tuesday, February 27th. JPMorgan Chase & Co. reduced their price objective on Provident Financial from GBX 1,100 ($14.76) to GBX 750 ($10.06) and set a neutral rating for the company in a research note on Thursday, May 10th. Barclays reissued an underweight rating and set a GBX 584 ($7.84) price objective on shares of Provident Financial in a research note on Wednesday, January 31st. Finally, Societe Generale lowered Provident Financial to a hold rating and set a GBX 1,050 ($14.09) price objective for the company. in a research note on Wednesday, February 28th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Provident Financial presently has a consensus rating of Hold and a consensus price target of GBX 1,190.14 ($15.97).

  • [By Logan Wallace]

    Provident Financial plc (LON:PFG) has received a consensus recommendation of “Hold” from the fifteen research firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 1,244.33 ($16.57).

  • [By ]

    Principal Financial Group (Nasdaq: PFG) is a diversified financial firm with $540 billion in assets under management and leadership in retirement investment products, fund investments and life insurance. The company missed Q2 earnings on non-recurring items which sent the shares skidding lower but core business in retirement income solutions and insurance remains solid.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Principal Financial Group (PFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Invest In Right Now: PJT Partners Inc.(PJT)

Advisors’ Opinion:

  • [By Shane Hupp]

    PJT Partners (NYSE:PJT) and MAN GRP PLC/ADR (OTCMKTS:MNGPY) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PJT Partners (PJT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Small Cap Stocks To Watch For 2019

Small cap electrocardiogram stock CardioComm Solutions (CVE: EKG; OTCMKTS: EKGGF) is taking ECGs to a new level. To begin with, an electrocardiogram is one of the most common diagnostic tests performed and is used to monitorthe heart to look for patterns amongheartbeats and rhythms to diagnose various heart conditions. Moreover and if someone has a family history of heart disease,an electrocardiogramis often used as an early screening test meaning its a commonly performed test.

However, its difficult to find updated statistics on how many electrocardiograms are performed every year and their market value. The market wasexpected to reach $157.9 million in 2015 with an annual growth rate of 3.7%, compared with a market valued at $122.2 million in 2008, according to estimates from market research firm GlobalData. However, their report noted:

Hot Small Cap Stocks To Watch For 2019: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c

Hot Small Cap Stocks To Watch For 2019: iShares Global Infrastructure (IGF)

Advisors’ Opinion:

  • [By Sarah Priestley]

    And if you are an investor who prefers ETFs and mutual funds, there are a couple of options for you: iShares Global Infrastructure ETF(NASDAQ:IGF), andLazard Global Listed Infrastructure(NASDAQMUTFUND:GLIFX). I would caution anybody tocheck the percentage of utilities that are within these baskets, just to check theutilities exposure. But, generally, not bad options to check out.

Hot Small Cap Stocks To Watch For 2019: BAE Systems PLC (BAESY)

Advisors’ Opinion:

  • [By Lou Whiteman]

    The Marine Corps has selected BAE Systems (NASDAQOTH:BAESY) to manufacture its next-generation amphibious combat vehicle, dealing a major setback to the diversification plans of Science Applications International (NYSE:SAIC).

Hot High Tech Stocks To Invest In Right Now

The fear over 10-year U.S. Treasury yields breaking through 3 percent has been a long time coming, according to Societe Generale SA.

“Interest rates are already doing damage, people just haven’t noticed,” Andrew Lapthorne, the firm’s global head of quantitative strategy, said in an interview Tuesday. “Leverage in the U.S. is grotesque for this stage of the cycle. At the moment you’ve got peak leverage at peak prices. It’s not like you have to dig deep to find a problem.”

The number-one conversation Societe Generale’s having with clients right now is about the correlation between bonds and equities. But risks to corporate balance sheets is a bigger problem at the moment, particularly in the U.S. and China. Lapthorne said he worries about volatility in debt because of the impact it can have on the economy, particularly how it weighs on businesses and the job market.

#lazy-img-327023302:before{padding-top:49.66666666666666%;}

Credit markets may get choppier due to triggers like high-profile bankruptcies, such as Toys ‘R’ Us, or if corporate buybacks drop, Lapthorne said. While Credit Suisse anticipates fewer share repurchases this year, they’re an outlier. JPMorgan Chase & Co. estimates they’ll rise to a record $800 billion from $530 billion last year. Bank of America Corp. said if the current pace continues there may be as much as $850 billion in 2018, while Goldman Sachs Group Inc. sees buybacks becoming “less constructive” in 2019.

Hot High Tech Stocks To Invest In Right Now: iShares Nasdaq Biotechnology Index Fund(IBB)

Advisors’ Opinion:

  • [By ]

    The SPDR S&P Biotech ETF (NYSE:XBI) a good measure of small-cap biotech stocks gained almost 6% yesterday. Meanwhile, the large-cap iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) jumped almost 4%. The biotech buying frenzy helped lift the Nasdaq Composite to a gain of almost 1% in Mondays session.

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)– which is an exchange-traded fund that holds nearly 200 biotech stocks — has drastically underperformed the S&P 500 over the last three years. That fact suggests that there are bargains to be found in the biotech space.

  • [By Benzinga News Desk]

    After eking out a modest gain in the week ended April 27, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) pulled back this week amid some not-so-encouraging earnings reports and negative regulatory decisions: Link

  • [By Jim Crumly]

    Biotech stocks had a big day, with theiShares NASDAQ Biotechnology ETF (NASDAQ:IBB) jumping 2.8%. The broad technology sector slipped, and theTechnology Select Sector SPDR ETF (NYSEMKT:XLK)lost 0.1%.

Hot High Tech Stocks To Invest In Right Now: Xplore Technologies Corp(XPLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Xplore Technologies (NASDAQ: XPLR) is one of 25 publicly-traded companies in the “Computer & office equipment” industry, but how does it compare to its peers? We will compare Xplore Technologies to related businesses based on the strength of its dividends, profitability, earnings, risk, valuation, analyst recommendations and institutional ownership.

  • [By Logan Wallace]

    A10 Networks (NYSE: ATEN) and Xplore Technologies (NASDAQ:XPLR) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.

Hot High Tech Stocks To Invest In Right Now: Central Valley Community Bancorp(CVCY)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Central Valley Community Bancorp (CVCY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot High Tech Stocks To Invest In Right Now: Bruker Corporation(BRKR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Bruker (BRKR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot High Tech Stocks To Invest In Right Now: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Hot High Tech Stocks To Invest In Right Now: FIRST REPUBLIC BANK(FRC)

Advisors’ Opinion:

  • [By Shane Hupp]

    Freicoin (FRC) is a proof-of-work (PoW) coin that uses the
    SHA-256 hashing algorithm. It launched on December 21st, 2012. Freicoin’s total supply is 100,000,000 coins and its circulating supply is 31,000,264 coins. Freicoin’s official Twitter account is @Freicoin and its Facebook page is accessible here. Freicoin’s official website is freico.in. Freicoin’s official message board is freicoinalliance.com.

  • [By Max Byerly]

    MUFG Americas Holdings Corp lessened its position in shares of First Republic Bank (NYSE:FRC) by 19.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 13,956 shares of the bank’s stock after selling 3,360 shares during the period. MUFG Americas Holdings Corp’s holdings in First Republic Bank were worth $1,292,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Motley Fool Staff]

    First Republic Bank (NYSE:FRC) Q1 2018 Earnings Conference CallApril 13, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Mackay Shields LLC bought a new stake in First Republic Bank (NYSE:FRC) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 12,402 shares of the bank’s stock, valued at approximately $1,149,000.

  • [By Ethan Ryder]

    Commerce Bank lessened its stake in shares of First Republic Bank (NYSE:FRC) by 76.8% in the 1st quarter, HoldingsChannel reports. The fund owned 56,614 shares of the bank’s stock after selling 187,752 shares during the period. Commerce Bank’s holdings in First Republic Bank were worth $5,243,000 at the end of the most recent quarter.

Top 10 Heal Care Stocks To Buy For 2018

There are currently 13,373 publicly-traded securities on U.S. exchanges. Of those, there are 2,100 stocks currently paying a dividend.

Now, any knucklehead with a computer can generate a list of the market’s highest-yielding stocks in five minutes, but that’s no way to find a good investment. Investing is not as simple as buying anything with a double-digit yield.

—Sponsored Link—

Ignore All Doubters.The Perfect Investment Does Exist
Every investor faces the same dilemma — Shoot for huge returns. and you put way too much capital at risk. Choose safety and your cash is spread so thin you barely break even. Our brand new primer “The Right Investment at the Perfect Time” reveals a simple way to stay in one single investment. while enjoying ALL the benefits of full diversification! CLICK HERE to put this little-known technique to work for you.

I’ve warned readers before about blindly buying these super-aggressive yielders. Nine times out of 10, a stock yielding more than 15% is likely in big trouble.

Top 10 Heal Care Stocks To Buy For 2018: Pinnacle West Capital Corporation(PNW)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Atria Investments LLC cut its stake in shares of Pinnacle West Capital Co. (NYSE:PNW) by 49.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,651 shares of the utilities provider’s stock after selling 4,560 shares during the period. Atria Investments LLC’s holdings in Pinnacle West Capital were worth $371,000 as of its most recent filing with the SEC.

  • [By Logan Wallace]

    Bank of America upgraded shares of Pinnacle West Capital (NYSE:PNW) from an underperform rating to a neutral rating in a research note issued to investors on Friday morning, Marketbeat.com reports. Bank of America currently has $81.00 target price on the utilities provider’s stock. The analysts noted that the move was a valuation call.

  • [By Joseph Griffin]

    M&T Bank Corp raised its position in Pinnacle West Capital Co. (NYSE:PNW) by 15.8% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 8,775 shares of the utilities provider’s stock after purchasing an additional 1,196 shares during the period. M&T Bank Corp’s holdings in Pinnacle West Capital were worth $700,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    ING Groep NV lifted its holdings in shares of Pinnacle West Capital Co. (NYSE:PNW) by 7.5% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,423 shares of the utilities provider’s stock after acquiring an additional 800 shares during the quarter. ING Groep NV’s holdings in Pinnacle West Capital were worth $912,000 at the end of the most recent quarter.

  • [By Jon C. Ogg]

    Pinnacle West Capital Corp. (NYSE: PNW) was raised to Outperform from Neutral and the price target was raised to $87 from $85 at Credit Suisse.

    Salesforce.com Inc. (NYSE: CRM) was reiterated as Outperform and the price target was raised to $140 from $125 at JMP Securities.

Top 10 Heal Care Stocks To Buy For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Oil prices are at levels we haven’t seen in years. U.S. crude topped $70 for the first since 2014, as U.S. President Donald Trump appeared increasingly likely to pull out of the Iran nuclear deal and reinforce sanctions on Tehran. In addition, OPEC has announced plans to bolster prices and cap production. For oil investors, Money MorningGlobal Energy Strategist Dr. Kent Moors says it’s time to buckle up. According to Moors, revoking the Iran deal would cause “price chaos” around the globe. And that’s right as driving season starts in the United States. Here’s more on the coming chaos for oil. In deal news, Blackstone Group (NYSE: BX) announced it will purchase Gramercy Property Trust (NYSE: GPT) for $7.6 billion in cash. Grammercy manages commercial real estate. While this may seem like a boring deal, Blackstone is buying a business that churns out cold hard cash for its investors. We want to keep this deal on your radar, because there are many other deals like this coming down the pipeline. We’re going to be discussing one of the best real estate opportunities available very soon – so keep an eye out for updates.
    Three Stocks to Watch Today: AMZN, AAPL, TSN, SBUX
    Shareholders of Amazon.com Inc. (Nasdaq: AMZN) cheered statements made by Warren Buffett over the weekend. The Oracle of Omaha said he messed up by not investing in Amazon and Alphabet Inc. (Nasdaq: GOOGL). “I made the wrong decisions on Google and Amazon,” Buffett said on Saturday. “We’ve looked at it. I made the mistake in not being able to come to a conclusion where I really felt that at the present prices that the prospects were far better than the prices indicated.” Buffett says he now has a “very, very, very high opinion” of Amazon CEO Jeff Bezos. The Oracle believes that Bezos has created something that is “close to a miracle.” Apple Inc. (Nasdaq: AAPL) added another 0.6% Monday, to reach $185.00 per share – a new 52-week high. The uptick came after Warren Buffett announced

  • [By Lisa Levin] Companies Reporting Before The Bell
    Tyson Foods, Inc. (NYSE: TSN) is projected to report quarterly earnings at $1.32 per share on revenue of $9.89 billion.
    Sysco Corporation (NYSE: SYY) is estimated to report quarterly earnings at $0.64 per share on revenue of $14.34 billion.
    Louisiana-Pacific Corporation (NYSE: LPX) is expected to report quarterly earnings at $0.67 per share on revenue of $692.63 million.
    Cognizant Technology Solutions Corporation (NASDAQ: CTSH) is estimated to report quarterly earnings at $1.06 per share on revenue of 3.90 billion.
    Manchester United plc (NYSE: MANU) is estimated to report quarterly loss at $1.35 per share on revenue of $193.67 million.
    Sempra Energy (NYSE: SRE) is expected to report quarterly earnings at $1.66 per share on revenue of $3.24 billion.
    Willis Towers Watson Public Limited Company (NYSE: WLTW) is projected to report quarterly earnings at $3.01 per share on revenue of $2.23 billion.
    Green Plains Inc. (NASDAQ: GPRE) is estimated to report quarterly loss at $0.28 per share on revenue of $922.42 million.
    TravelCenters of America LLC (NASDAQ: TA) is projected to report quarterly loss at $0.16 per share on revenue of $1.59 billion.
    Gannett Co., Inc. (NYSE: GCI) is expected to report quarterly earnings at $0.03 per share on revenue of $723.93 million.
    Welbilt, Inc. (NYSE: WBT) is estimated to report quarterly earnings at $0.11 per share on revenue of $329.71 million.
    Horizon Pharma Public Limited Company (NASDAQ: HZNP) is projected to report quarterly earnings at $0.07 per share on revenue of $234.17 million.

     

  • [By Joseph Griffin]

    State Board of Administration of Florida Retirement System lowered its holdings in shares of Cognizant (NASDAQ:CTSH) by 1.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 837,118 shares of the information technology service provider’s stock after selling 11,877 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Cognizant were worth $67,388,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Paradigm Asset Management Co. LLC reduced its stake in Cognizant (NASDAQ:CTSH) by 6.2% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,900 shares of the information technology service provider’s stock after selling 2,100 shares during the period. Paradigm Asset Management Co. LLC’s holdings in Cognizant were worth $2,568,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Heal Care Stocks To Buy For 2018: Werner Enterprises, Inc.(WERN)

Advisors’ Opinion:

  • [By Max Byerly]

    Werner Enterprises (NASDAQ: WERN) and Universal Logistics (NASDAQ:ULH) are both transportation companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.

  • [By ]

    Werner Enterprises (Nasdaq: WERN) competes in the full-truckload (FTL) segment of the industry where drivers deliver entire truck-loads between two points, rather than making many stops to consolidate partial loads as in the LTL segment. This could mean that the company has relatively more to gain from autonomous trucking since highway driving is a larger portion of total drive time.

Top 10 Heal Care Stocks To Buy For 2018: Karyopharm Therapeutics Inc.(KPTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Karyopharm Therapeutics (NASDAQ:KPTI) – Investment analysts at Jefferies Group lowered their Q2 2018 earnings estimates for Karyopharm Therapeutics in a research note issued on Tuesday, May 15th. Jefferies Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($0.77) for the quarter, down from their prior estimate of ($0.62). Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Karyopharm Therapeutics’ Q3 2018 earnings at ($0.71) EPS, Q4 2018 earnings at ($0.78) EPS, FY2018 earnings at ($3.03) EPS, FY2019 earnings at ($2.66) EPS, FY2020 earnings at ($1.05) EPS, FY2021 earnings at ($0.74) EPS and FY2022 earnings at $0.73 EPS.

  • [By Stephan Byrd]

    Karyopharm Therapeutics (NASDAQ:KPTI) last issued its quarterly earnings data on Thursday, March 15th. The company reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.66) by ($0.14). The business had revenue of $1.53 million during the quarter, compared to the consensus estimate of $2.26 million. During the same quarter in the prior year, the firm posted ($0.65) earnings per share. The company’s revenue for the quarter was up 3163.8% compared to the same quarter last year. analysts anticipate that Karyopharm Therapeutics will post -2.82 earnings per share for the current fiscal year.

  • [By Shane Hupp]

    Karyopharm Therapeutics Inc (NASDAQ:KPTI) – Wedbush issued their Q1 2019 earnings estimates for Karyopharm Therapeutics in a research note issued on Thursday, May 24th. Wedbush analyst D. Nierengarten expects that the company will earn ($0.75) per share for the quarter. Wedbush has a “Neutral” rating and a $19.00 price target on the stock. Wedbush also issued estimates for Karyopharm Therapeutics’ Q2 2019 earnings at ($0.75) EPS, Q3 2019 earnings at ($0.71) EPS and Q4 2019 earnings at ($0.67) EPS.

  • [By Benzinga News Desk]

    Shari Redstone is one “disloyal” media heiress, according to CBS (NYSE: CBS): Link

    ECONOMIC DATA
    US Initial Jobless Claims for May 18 234.0K vs 220.0K Est; Prior 222.0K. US Continuing Claims for May 11 1.74M vs 1.75M Est; Prior 1.71M
    Existing home sales report for April will be released at 10:00 a.m. ET.
    The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.
    Atlanta Fed President Raphael Bostic will speak at 10:35 a.m. ET.
    The Treasury is set to auction 7-year notes at 1:00 p.m. ET.
    The Kansas City Fed manufacturing index for May will be released at 11:00 a.m. ET.
    Philadelphia Federal Reserve Bank President Patrick Harker is set to speak at 2:00 p.m. ET.
    Data on money supply for the latest week will be released at 4:30 p.m. ET.
    ANALYST RATINGS
    UBS upgrades Deere (NYSE: DE) from Neutral to Buy
    Wells Fargo upgrades Oceaneering (NYSE: OII) from Market Perform to Outperform
    Canaccord downgrades Vermillion (NASDAQ: VRML) from Buy to Hold
    Wedbush downgrades Karyopharm Therapeutics (NASDAQ: KPTI) from Outperform to Neutral

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Top 10 Heal Care Stocks To Buy For 2018: Flanigan’s Enterprises Inc.(BDL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Blink Charging Co. (NASDAQ: BLNK) shares jumped 26.5 percent to $6.9042. Blink Charging reported Q1 net income of $2.2 million, versus a year-ago net loss of $3.1 million.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares climbed 17.4 percent to $3.11. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share.
    Flanigan's Enterprises, Inc. (NYSE: BDL) shares jumped 17 percent to $27.97 following Q2 results. Flanigan's Enterprises posted Q2 earnings of $0.75 per share on sales of $29.456 million.
    Borqs Technologies, Inc. (NASDAQ: BRQS) rose 15.8 percent to $8.05 after reporting Q1 results.
    Abaxis, Inc. (NASDAQ: ABAX) jumped 15.3 percent to $82.75. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 15.1 percent to $6.33.
    Gemphire Therapeutics Inc. (NASDAQ: GEMP) rose 13.8 percent to $6.27.
    Enphase Energy, Inc. (NASDAQ: ENPH) gained 12.8 percent to $5.98. H.C. Wainwright initiated coverage on Enphase Energy with a Buy rating.
    PetIQ Inc (NASDAQ: PETQ) shares surged 12.1 percent to $21.68 after reporting a first-quarter sales beat.
    NF Energy Saving Corporation (NASDAQ: NFEC) climbed 11.6 percent to $2.399.
    Allied Healthcare Products, Inc. (NASDAQ: AHPI) surged 11.4 percent to $3.0643.
    Boot Barn Holdings, Inc. (NYSE: BOOT) gained 11.1 percent to $24.40 after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance.
    Ascena Retail Group, Inc. (NASDAQ: ASNA) rose 10.9 percent to $3.16.
    Sea Limited (NYSE: SE) gained 10.1 percent to $11.71 after reporting Q1 results.
    GEE Group, Inc. (NYSE: JOB) climbed 7.9 percent to $2.61 following Q2 results.
    The ONE Group Hospitality, Inc. (NASDAQ: STKS) gained 7.6 percent to $2.41 after reporting Q1 results.
    Biolinerx Ltd/S ADR (NASDAQ: BLRX) rose 7.3 percent to $0.8798 after the company was granted a patent approval. The clinical-st

Top 10 Heal Care Stocks To Buy For 2018: Zogenix, Inc.(ZGNX)

Advisors’ Opinion:

  • [By Sean Williams]

    The other concern is that while it may be the first to market in treating Dravet syndrome and Lennox-Gastaut syndrome, another experimental therapy is nipping at its heels. In September, Zogenix (NASDAQ:ZGNX) announced surprisingly strong phase 3 data for ZX008, a low-dose fenfluramine that absolutely blew away the placebo in Dravet syndrome patient testing. Zogenix’s lead compound led to a 72.4% reduction in convulsive seizure frequency over a 14-week period, compared to the 17.4% reduction for placebo patients.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Zogenix (ZGNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Sean Williams]

    Back in September, drug developer Zogenix (NASDAQ:ZGNX) announced data from ZX008 in late-stage trials that absolutely wowed Wall Street. ZX008, which is a low-dose fenfluramine, led to a 72.4% reduction in seizure frequency from baseline over a 14-week testing period. This compared very favorably with a 17.4% reduction in seizure frequency from baseline observed with the placebo.

  • [By Sean Williams]

    But what’s interesting about Epidiolex is that its first-to-market advantage may not hold up for too long. You see, Zogenix (NASDAQ:ZGNX)also is developing a treatment for Dravet syndrome, known as ZX008, that it plans to test on LGS patients soon. In phase 3 Dravet syndrome trials, Zogenix’s lead drug wound up demonstrating a 72.4% reduction in convulsive seizure frequency over the 14-week treatment period relative to baseline. This more than quadrupled the 17.4% reduction in convulsive seizure frequency seen in placebo patients.

  • [By Logan Wallace]

    DekaBank Deutsche Girozentrale bought a new stake in Zogenix (NASDAQ:ZGNX) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 14,700 shares of the company’s stock, valued at approximately $575,000.

Top 10 Heal Care Stocks To Buy For 2018: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Heal Care Stocks To Buy For 2018: Potash Corporation of Saskatchewan Inc.(POT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Headlines about Potash Co. of Saskatchewan (NYSE:POT) (TSE:POT) have trended positive this week, according to Accern Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Potash Co. of Saskatchewan earned a news impact score of 0.43 on Accern’s scale. Accern also gave media coverage about the fertilizer maker an impact score of 45.4285202328488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Joseph Griffin]

    PotCoin (CURRENCY:POT) traded 0.6% higher against the US dollar during the 24 hour period ending at 23:00 PM E.T. on May 12th. PotCoin has a total market capitalization of $23.95 million and approximately $62,522.00 worth of PotCoin was traded on exchanges in the last 24 hours. During the last seven days, PotCoin has traded 17.8% lower against the US dollar. One PotCoin coin can now be purchased for approximately $0.11 or 0.00001293 BTC on popular cryptocurrency exchanges including Cryptopia, CoinExchange, Trade By Trade and Tux Exchange.

Top 10 Heal Care Stocks To Buy For 2018: Heron Therapeutics, Inc. (HRTX)

Advisors’ Opinion:

  • [By Jason Hall, George Budwell, and Chuck Saletta]

    And while it may not always work out well to simply copy the moves other investors make, it can pay off to use their buying and selling moves as jumping-off points in your own research. We asked three real-world investors for their insight, and they wrote about two recent Buffett buys ofApple Inc.(NASDAQ:AAPL) andUSG Corporation(NYSE:USG), and a recent Baker Brothers buy ofHeron Therapeutics Inc(NASDAQ:HRTX).

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Top 10 Heal Care Stocks To Buy For 2018: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is poised to post its most recent quarterly results before regular trading begins on Thursday. The consensus forecast is $0.66 in EPS and $4.80 billion in revenue. Shares closed at $17.83 apiece. The consensus price target is $19.33, and the 52-week range is $10.850 to $33.82.

  • [By ]

    Teva Pharmaceutical Industries Ltd.  (TEVA) isn’t out of the weeds just yet.

    Teva’s shares finished in the red, despite a strong earnings beat and further measures to reduce its $30 billion-plus debt pile. Though things appear to be turning Teva shares closed down 4.4% to $17.78.

  • [By Trey Thoelcke]

    Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Eli Lilly & Co. (NYSE: LLY) are among companies developing similar treatments.

    Stewart J. Tepper, MD, Professor of Neurology at the Geisel School of Medicine at Dartmouth Medical School, said:

  • [By Cory Renauer]

    Warren Buffett’s famous for telling investors to be greedy when others are fearful, but buying Teva Pharmaceuticals Industries(NYSE:TEVA) last year seemed like searching for loose change in a burning building. Generic drug prices began collapsing just after the company borrowed heavily to become the world’s largest generic drug producer, and that was just one disaster of many that forced the company to slash its dividend last year.

  • [By Garrett Baldwin]

    Yesterday, the Fed Open Market Committee announced it would not raise interest rates this session. The central bank committee, which is in charge of monetary policy, said that inflation is rising and that the U.S. economy is getting better. Markets are now looking forward to the next meeting on June 12 for the U.S. Federal Reserve to bump rates higher for the second time in 2018. Shares of Tesla Inc. (Nasdaq: TSLA) slumped more than 4.5% after Tesla CEO Elon Musk held an highly unusual earnings call. After announcing that his firm burned through $700 million in cash during the quarter of 2018, Musk refused to take any more questions on the company’s fiscal health, dismissing analysts’ questions as “boring.” Musk instead spent the rest of the quarterly call taking questions from a YouTuber named Gali Russell who had lobbied Musk on Twitter to let him partake in the earnings call. This morning, the U.S. Labor Department reported initial jobless claims rose by 2,000, to 211,000. Analysts had projected 225,000 for the week. The tightening U.S. labor market has now seen the total number of Americans receiving benefits fall to the lowest level since 1973. America’s unemployment rate is sitting at 4.1%, the lowest figure in 17 years. Tomorrow, the Labor Department will release the April jobs report.
    Four Stocks to Watch Today: GPRO, SPOT, CI
    GoPro Inc. (Nasdaq: GPRO) will lead another busy day of earnings reports on Wall Street. The firm will report earnings after the bell Thursday. Wall Street expects that the tech firm is about to report a loss of -$0.40 per share on top of $175.40 billion in revenue. Here’s a way to make a lot of money in a short time during earnings season. Spotify Technology SA(NYSE: SPOT) did not have a very good first earnings report. Shares plunged more than 8% after the firm’s music-streaming forecasts fell well short of expectations. During its earnings report, signals indicated that the firm’s growth could slow despite news that its

Best Warren Buffett Stocks To Watch Right Now

&l;p&g;&l;img class=&q;dam-image ap size-large wp-image-e7c1fea794254dd6bb98ec759192c6ee&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/e7c1fea794254dd6bb98ec759192c6ee/960×0.jpg?fit=scale&q; data-height=&q;649&q; data-width=&q;960&q;&g; Warren Buffett, Chairman and CEO of Berkshire Hathaway, speaks to reporters during a tour of the exhibit floor at the CenturyLink Center in Omaha, Neb., Saturday, May 5, 2018, where Berkshire brands display their products and services. Tens of thousands of Berkshire Hathaway shareholders have arrived in Omaha for the annual shareholders meeting, where Buffett and his Vice-Chairman Charlie Munger preside over a Q&a;amp;A session. (AP Photo/Nati Harnik)

Today, at the 2018 Berkshire Hathaway Annual Meeting, Warren Buffett and his partner, Charlie Munger, shared their continuing faith in the U.S. stock market, as well as reasons for pessimism on other assets such as crypto-currencies, bonds and gold. They discussed how their investment strategy has evolved. They are now happy owning more capital intensive businesses, such as railroads and utilities. In a more colorful moment, Munger described trading crypto-currencies as, &q;trading turds&q;.

Best Warren Buffett Stocks To Watch Right Now: SBA Communications Corporation(SBAC)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Tuesday was another good day on Wall Street, thanks largely to diminished concerns about trade disputes between the U.S. and China. Chinese leaders made conciliatory comments that suggested that there could be a measured resolution to tensions between the two countries, and market participants took that as an all-clear sign to bid shares higher. Yet some stocks suffered from negative news. Tupperware Brands (NYSE:TUP), SBA Communications (NASDAQ:SBAC), and American Airlines Group (NASDAQ:AAL) were among the worst performers on the day. Here’s why they did so poorly.

Best Warren Buffett Stocks To Watch Right Now: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D

Best Warren Buffett Stocks To Watch Right Now: Dril-Quip, Inc.(DRQ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Dril-Quip (NYSE: DRQ) is one of 14 public companies in the “Oil & gas field machinery” industry, but how does it contrast to its competitors? We will compare Dril-Quip to related companies based on the strength of its risk, valuation, analyst recommendations, profitability, dividends, institutional ownership and earnings.

Best Warren Buffett Stocks To Watch Right Now: Monotype Imaging Holdings Inc.(TYPE)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Monotype Imaging (NASDAQ:TYPE) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.

Best Warren Buffett Stocks To Watch Right Now: Public Service Enterprise Group Incorporated(PEG)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Public Service (NYSE:PEG) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Public Service earned a media sentiment score of 0.04 on Accern’s scale. Accern also gave headlines about the utilities provider an impact score of 46.5923185859882 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    FDx Advisors Inc. lowered its stake in shares of Public Service Co. (NYSE:PEG) by 15.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 36,891 shares of the utilities provider’s stock after selling 6,935 shares during the quarter. FDx Advisors Inc.’s holdings in Public Service were worth $1,853,000 as of its most recent SEC filing.

Best Warren Buffett Stocks To Watch Right Now: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Stocks To Buy For 2018

The high-flying Indian IT outsourcing industry has withstood several challenges in the past. However, a recent obstacle has sent the industry into a tailspin, as these firms scurry around to identify strategies to work around the hindrance.

The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

Top 10 Stocks To Buy For 2018: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.

Top 10 Stocks To Buy For 2018: Barclays PLC(BCS)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Some of this sentiment has been fueled by optimism that UK investment bank Barclays Plc. (NYSE: BCS) is looking to open a cryptocurrency trading desk in the months ahead.

  • [By Eric Volkman]

    The underwriting syndicate is large and star-studded. It is led by Morgan Stanley (NYSE: MS), JPMorgan Chase’s(NYSE:JPM)J.P. Morgan Securities, Barclays (NYSE: BCS) Capital, and Citigroup (NYSE: C) Global Markets.

  • [By Matthew Cochrane]

    In Kenya, 28 million consumers can now seamlessly integrate their M-Pesa accounts with PayPal. In Spain, CaixaBank and Bankia both further integrated their online sites with PayPal. HSBC Holdings PLC (NYSE:HSBC) now allows corporate customers in the U.K. to pay distributions to beneficiaries through PayPal, a capability to be rolled out across Europe in the coming months. Barclays PLC (NYSE:BCS) announced a strategic partnership that enables its customers to more easily link their accounts to PayPal, and soon to use their reward points on PayPal’s digital platform.

  • [By Garrett Baldwin]

    Investors are becoming increasingly bullish about BTC, as financial institutions like Barclays Plc. (NYSE: BCS) become more interested in entering the cryptocurrency market.

  • [By Matthew Frankel]

    Apple (NASDAQ:AAPL) is teaming up with investment banking giant Goldman Sachs (NYSE:GS) to develop and launch a new co-branded credit card next year, according to a report in the Wall Street Journal. This would replace the tech giant’s current partnership with Barclays (NYSE:BCS), and would be issued under the Apple Pay brand name.

Top 10 Stocks To Buy For 2018: Illinois Tool Works Inc.(ITW)

Advisors’ Opinion:

  • [By ]

    Cramer and the AAP team are trimming Illinois Tool Works (ITW) and Danaher (DHR) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    Cramer and the AAP team are trimming Illinois Tool Works (ITW) and Danaher (DHR) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

  • [By ]

    Illinois Tools Works (ITW) shares fell after the company’s earnings report, but Cramer and the AAP team see it as an opportunity to buy more shares. Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Top 10 Stocks To Buy For 2018: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Top 10 Stocks To Buy For 2018: InfraREIT, Inc.(HIFR)

Advisors’ Opinion:

  • [By Shane Hupp]

    Reaves W H & Co. Inc. trimmed its holdings in InfraREIT (NYSE:HIFR) by 18.4% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,342,026 shares of the real estate investment trust’s stock after selling 303,392 shares during the quarter. Reaves W H & Co. Inc. owned approximately 3.05% of InfraREIT worth $26,076,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on InfraREIT (HIFR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2018: Smith Micro Software Inc.(SMSI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the news stories that may have impacted Accern’s scoring:

    Get Smith Micro Software alerts:

    Short Interest in Smith Micro Software (SMSI) Increases By 51.9% (americanbankingnews.com) Smith Micro Software’s (SMSI) CEO Bill Smith on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) Smith Micro Software (SMSI) Reports Q1 Loss of $0.10 (streetinsider.com) Smith Micro Reports First Quarter 2018 Financial Results (finance.yahoo.com) Smith Micro announces above market USD 7.0m private placement offering (financial-news.co.uk)

    Separately, ValuEngine upgraded shares of Smith Micro Software from a “sell” rating to a “hold” rating in a report on Friday, February 2nd.

Top 10 Stocks To Buy For 2018: Targa Resources, Inc.(TRGP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Targa Resources (NYSE:TRGP) was downgraded by equities research analysts at ValuEngine from a “hold” rating to a “sell” rating in a research note issued on Wednesday.

  • [By Max Byerly]

    Reaves W H & Co. Inc. trimmed its holdings in Targa Resources (NYSE:TRGP) by 30.6% in the first quarter, HoldingsChannel reports. The institutional investor owned 224,657 shares of the pipeline company’s stock after selling 99,015 shares during the period. Reaves W H & Co. Inc.’s holdings in Targa Resources were worth $9,885,000 at the end of the most recent reporting period.

Top 10 Stocks To Buy For 2018: Standex International Corporation(SXI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Synex International (TSE:SXI) Director Glenn Stanley Mcdonnell sold 250,000 shares of the stock in a transaction on Wednesday, May 2nd. The stock was sold at an average price of C$0.50, for a total transaction of C$125,000.00.

Top 10 Stocks To Buy For 2018: BlackRock, Inc.(BLK)

Advisors’ Opinion:

  • [By ]

    Others think the muted market reaction to solid earnings from financial services giants such as JPMorgan & Chase (JPM) , BlackRock (BLK) and Bank of America (BAC) hint at a market just itching to sell off again. JPMorgan is a holding in Jim Cramer’s Action Alerts PLUS.

  • [By ]

    BlackRock Inc. (BLK) , the largest U.S. money manager with more than $6 trillion of customer assets, said earlier this year that it wants publicly-traded companies to have at least two female directors on every board. State Street Corp. (STT) , which oversees $2.7 trillion of fund assets, says it voted against the re-election of directors at 400 companies last year because they failed to take meaningful action to increase board diversity.

  • [By Chris Lange]

    BlackRock Inc.’s (NYSE: BLK) fourth-quarter earnings resultswill be compared with consensus estimates of $5.97 in earnings per share (EPS) and $3.3 billion in revenue. Its shares closed trading at $525.57 apiece on Friday. The consensus price target is $542.00, and the 52-week trading range is $365.83 to $525.94.

  • [By ]

    BlackRock Inc. (BLK) , the world’s largest publicly traded money manager, said first-quarter profit surged 27% as investors continued to pour money into its iShares exchange-traded funds at the expense of mutual-fund firms focused on active stock-picking.

Top 10 Stocks To Buy For 2018: Dave & Buster's Entertainment, Inc.(PLAY)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY)updated guidance for its fiscal 2017 (which ends on February 4, 2018):

  • [By Paul Ausick]

    Dave & Buster’s Entertainment Inc. (NASDAQ: PLAY) traded down nearly 22% Monday and posted a new 52-week low of $44.00 after closing Friday at $56.37. The 52-week high is $73.48. Volume was about 7.5 million, more than six times the daily average of around 1.2 million shares. The company lowered fourth quarter guidance this morning.

  • [By Trey Thoelcke]

    Dave & Buster’s Entertainment Inc.’s (NASDAQ: PLAY) fiscal fourth-quarter report is scheduled for Tuesday after the markets close. The consensus estimates are $0.60 in earnings per share (EPS) on $305.49 million in revenue. The shares ended the week at $41.74. The consensus price target is $65.33, and the 52-week trading range is $41.04 to $73.48.

Hot Performing Stocks To Watch For 2019

We have been fans of Swedbank (OTCPK:SWDBY) (OTCPK:SWDBF) for quite a while now. In July 2016, we published our first article on the name. At the time, Swedbank was offering a very compelling investment case. It was hard not to be bullish on the stock given its predictable revenue stream, robust asset quality trends, rock-solid capital ratios, appealing valuation multiples, and a very attractive dividend yield. Since then, the stock has had a good run, especially after taking into account the dividend. With that being said, Swedbank had a weak 2017. In fact, it was one of the worst-performing banking stocks in the Nordic region. Such a weak performance is mainly attributed to investor concerns regarding a potential bubble in the Swedish housing market. Indeed, after more than 10 years of impressive growth, property prices in Sweden have decreased by almost 10% since September 2017. However, the country’s macroeconomic environment remains robust. In our view, even a prolonged correction in the Sweden’s housing market should not be an issue for Swedbank’s asset quality, especially given its solid balance sheet and low loan-to-value ratios. As such, we believe market fears are overblown. With the stock trading at just 11x forward earnings and a 6.4% dividend, Swedbank is a buy, in our view.

Hot Performing Stocks To Watch For 2019: OncoCyte Corporation(OCX)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

Hot Performing Stocks To Watch For 2019: Arista Networks, Inc.(ANET)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Arista Networks (NYSE:ANET) Q1 2018 Earnings Conference CallMay. 3, 2018 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Check-Cap Ltd. (NASDAQ: CHEK) shares dipped 47.8 percent to $4.60. Check-Cap priced its upsized underwritten offering of public units at $5.50 per unit.
    VivoPower International PLC (NASDAQ: VVPR) shares fell 41.5 percent to $2.57.
    Universal Electronics Inc. (NASDAQ: UEIC) dropped 35.1 percent to $29.50 after the company posted downbeat quarterly results.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) dropped 34.8 percent to $3.75 after climbing 155.56 percent on Thursday.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 25.2 percent to $24.01 after surging 46.29 percent on Thursday.
    Fluor Corporation (NYSE: FLR) dropped 22.5 percent to $45.73 after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 19.6 percent to $52.075 following Q1 earnings.
    Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares declined 18.1 percent to $5.20. Adverum Biotech disclosed that its CEO Amber Salzman is stepping down.
    Newater Technology, Inc. (NASDAQ: NEWA) dropped 17.2 percent to $12.83.
    Basic Energy Services, Inc. (NYSE: BAS) fell 17.2 percent to $13.65 following Q1 results.
    Xperi Corporation (NASDAQ: XPER) declined 15.8 percent to $19.40 after announcing Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 15.1 percent to $3.649 after climbing 22.16 percent on Thursday.
    Performant Financial Corporation (NASDAQ: PFMT) dropped 14.2 percent to $2.65.
    Gogo Inc. (NASDAQ: GOGO) shares fell 13.2 percent to $8.32 after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Technical Communications Corporation (NASDAQ: TCCO) dropped 12.2 percent to $5.05.
    Web.com Group, Inc. (NASDAQ: WEB) fell 9.7 percent

  • [By Dan Caplinger]

    Wall Street had its Cinco de Mayo celebration a day early, as the Dow Jones Industrial Average finished the session with a gain of more than 330 points. Investors were excited about what they saw as a Goldilocks-like reading on the U.S. economy in the April employment report, which featured modest job growth, rock-bottom unemployment rates, and slow enough wage growth to quell inflation fears and give the Federal Reserve latitude to raise interest rates more slowly going forward. Yet some companies still suffered at least perceived setbacks that sent their shares lower. Fluor (NYSE:FLR), Arista Networks (NYSE:ANET), and Appian (NASDAQ:APPN) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    Arista Networks (ANET) : “That’s a great company with a great CEO.”

    Dr. Pepper Snapple (DPS) : “You need to wait until the merger closes, then it’ll be OK.”

  • [By Dan Caplinger]

    The stock market finished lower on Friday, with triple-digit losses for the Dow Jones Industrial Average and modest declines of as much as half a percent for other major benchmarks. A mix of economic and political news kept investors on their toes to end the week, as fears of a possible attack on Syria watered down some of the potential upside that could have stemmed from solid earnings results from the banking sector during the morning. Even though many investors have pretty positive expectations going into earnings season, some companies suffered from disappointing news that sent their shares lower. Arista Networks (NYSE:ANET), Dropbox (NASDAQ:DBX), and MBIA (NYSE:MBI) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Shane Hupp]

    Arista Networks (NYSE:ANET) last released its quarterly earnings data on Thursday, May 3rd. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.15. The business had revenue of $472.50 million during the quarter, compared to analysts’ expectations of $463.39 million. Arista Networks had a net margin of 27.19% and a return on equity of 28.72%. The firm’s quarterly revenue was up 40.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.93 EPS. equities research analysts anticipate that Arista Networks will post 6.02 EPS for the current fiscal year.

Hot Performing Stocks To Watch For 2019: iShares MSCI EAFE (EFA)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Smart Portfolios LLC acquired a new stake in shares of iShares MSCI EAFE ETF (NYSEARCA:EFA) during the 1st quarter, HoldingsChannel.com reports. The fund acquired 2,906 shares of the exchange traded fund’s stock, valued at approximately $202,000.

  • [By Stephan Byrd]

    SimpliFi Inc. lifted its position in iShares MSCI EAFE ETF (NYSEARCA:EFA) by 0.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 156,749 shares of the exchange traded fund’s stock after purchasing an additional 967 shares during the quarter. iShares MSCI EAFE ETF accounts for about 9.0% of SimpliFi Inc.’s holdings, making the stock its 6th largest holding. SimpliFi Inc.’s holdings in iShares MSCI EAFE ETF were worth $10,922,000 at the end of the most recent reporting period.

Hot Performing Stocks To Watch For 2019: Lennox International, Inc.(LII)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lessened its holdings in shares of Lennox International (NYSE:LII) by 12.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,403 shares of the construction company’s stock after selling 629 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Lennox International were worth $900,000 at the end of the most recent reporting period.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Halliburton Company (NYSE: HAL) to report quarterly earnings at $0.42 per share on revenue of $5.75 billion before the opening bell. Halliburton shares fell 0.06 percent to $51.93 in after-hours trading.
    Analysts expect Alphabet Inc. (NASDAQ: GOOGL) to post quarterly earnings at $9.33 per share on revenue of $30.31 billion after the closing bell. Alphabet shares gained 0.24 percent to $1,079.88 in after-hours trading.
    Before the markets open, Lennox International Inc. (NYSE: LII) is projected to report quarterly earnings at $1.09 per share on revenue of $815.16 million. Lennox shares dropped 2.84 percent to close at $197.08 on Friday.
    HNI Corporation (NYSE: HNI) reported retirement of its CEO Stan A. Askren and appointment of Jeffrey D. Lorenger as new CEO. HNI also reported strong earnings for its first quarter. HNI shares fell 3.17 percent to $34.20 in the after-hours trading session.
    Analysts are expecting Hasbro, Inc. (NASDAQ: HAS) to have earned $0.35 per share on revenue of $822.15 million in the latest quarter. Hasbro will release earnings before the markets open. Hasbro shares fell 0.39 percent to $82.49 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Kimberly-Clark Corporation (NYSE: KMB) is expected to report quarterly earnings at $1.71 per share on revenue of $4.60 billion.
    Halliburton Company (NYSE: HAL) is projected to report quarterly earnings at $0.42 per share on revenue of $5.75 billion.
    Lennox International Inc. (NYSE: LII) is estimated to report quarterly earnings at $1.09 per share on revenue of $815.16 million.
    Alaska Air Group, Inc. (NYSE: ALK) is projected to report quarterly loss at $0.12 per share on revenue of $1.82 billion.
    Hasbro, Inc. (NASDAQ: HAS) is expected to report quarterly earnings at $0.35 per share on revenue of $822.15 million.
    Lincoln Electric Holdings, Inc. (NASDAQ: LECO) is projected to report quarterly earnings at $1.08 per share on revenue of $729.83 million.
    Tennant Company (NYSE: TNC) is estimated to report quarterly earnings at $0.15 per share on revenue of $251.93 million.
    FirstEnergy Corp. (NYSE: FE) is projected to report quarterly earnings at $0.67 per share on revenue of $3.43 billion.
    Koninklijke Philips NV (ADR) (NYSE: PHG) is estimated to report earnings for its first quarter.
    Bank of Hawaii Corporation (NYSE: BOH) is expected to report quarterly earnings at $1.23 per share on revenue of $162.39 million.
    Avangrid, Inc. (NYSE: AGR) is projected to report quarterly earnings at $0.79 per share on revenue of $1.72 billion.

     

Hot Performing Stocks To Watch For 2019: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed this week:

    22nd Century Group Inc (NYSE: XXII): up 4.75 percent
    Aphria Inc (OTC: APHQF): up 16.9 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 1.1 percent
    Cannabis Sativa Inc (OTC: CBDS): up 3.4 percent
    CannTrust Holdings Inc (OTC: CNTTF): up 12.3 percent
    Canopy Growth Corp (OTC: TWMJF): up 1.6 percent
    Cronos Group Inc. (NASDAQ: CRON): up 4.1 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 3.7 percent
    Hiku Brands Company Ltd(OTC: DJACF): up 12.9 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 0.4 percent
    MassRoots Inc (OTC: MSRT): down 10.75 percent
    MedReleaf Corp(OTC: MEDFF): up 7.5 percent
    Scotts Miracle-Gro Co (NYSE: SMG): flat
    THC Biomed Intl Ltd (OTC: THCBF): down 0.25 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): down 9.8 percent
    In Other News

    GW Pharmaceuticals posted a second quarter net loss of $(3.12) per share on revenue of $3.35 million. Earnings missed estimates of $(2.22) per share but revenue beat expectations for $2 million in sales, surging 64.2 percent year-over-year.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed this week:

    22nd Century Group Inc (NYSE: XXII): up 9.4 percent
    Aphria Inc (OTC: APHQF): up 0.6 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 4.6 percent
    Cannabis Sativa Inc (OTC: CBDS): up 1.7 percent
    CannTrust Holdings Inc (OTC: CNTTF): up 22.8 percent
    Canopy Growth Corp (OTC: TWMJF): up 7.6 percent
    Cronos Group Inc. (NASDAQ: CRON): down 13.5 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 3.8 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 4.3 percent
    India Globalization Capital, Inc. (NYSE: IGC): up 5 percent
    MassRoots Inc (OTC: MSRT): up 12.1 percent
    MedReleaf Corp(OTC: MEDFF): up 16.8 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.3 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 3.8 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): down 1.4 percent
    In The News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey at this link. 

  • [By ]

    What are the risks? First off, the Cannabis market in Canada is already competitive, and it’s the fifth largest company behind the likes of Canopy (OTCPK:TWMJF), Aurora (OTCQX:ACBFF), Aphria (OTCQB:APHQF), Medreleaf (OTCPK:MEDFF), and Cronos (OTC:CRON). What’s more, there are approximately 228 million fully diluted shares, selling at $3.16/share ($4.04/share $CAD), and the company generated $CAD4.09mm in 2017 revenues. That’s quite a premium, and Hydropothecary Corp. trades expensively at a 225x sales multiple. Caveat emptor.

  • [By Keith Speights]

    So far, 2018 isn’t turning out like shareholders of Aphria (NASDAQOTH:APHQF) and Emerald Health Therapeutics (NASDAQOTH:EMHTF) hoped. Aphria stock is down 45% year to date, while Emerald Health is down 16%. Several issues, including dilution caused by offering new shares and a delay in thelegalization of recreational marijuana in Canada, havetaken a toll on both stocks.

  • [By ]

    As of the time of this writing, the average price to sales ratio of the large Canadian cannabis producers is 40 (Aurora (OTCQX:ACBFF): 33; Canopy (OTCPK:TWMJF): 65; Aphria (OTCQB:APHQF): 28.5; MedReleaf (OTCPK:MEDFF): 35). Given iAnthus’ vertical integration and lack of competition, their margins should be significantly better than any of those firms. However, since they operate in the US where there is greater legal risk, we will reduce that multiple by half. Assuming the low end of expected revenue for 2018 of $20 million, and a P/S of 20, we arrive at a valuation of $400,000,000, giving us a one year price target of $5/share.